Improvements in Dietary Quality and Health Behaviors in Telemedicine Patients Taking GLP-1’s Within a GLP-1 Specific Behavioral Program

Improvements in Dietary Quality and Health Behaviors in Telemedicine Patients Taking GLP-1’s Within a GLP-1 Specific Behavioral Program

Saved in:

Bibliographic Details
Main Authors:	Michelle Cardel, Gary D Foster, Leslie Heinberg, Kelli Richardson, Alexandra M Lee
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Current Developments in Nutrition
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475299125026666
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
by: Li Yang, et al.
Published: (2021-01-01)

GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity
by: Vijay Kumar
Published: (2025-07-01)

Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
by: Cheney C, et al.
Published: (2025-05-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series
by: William H Herman, et al.
Published: (2025-04-01)

Exploring the GLP-1–GLP-1R axis in porcine pancreas and gastrointestinal tract in vivo by ex vivo autoradiography
by: Jens Juul Holst, et al.
Published: (2021-03-01)

Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
by: Chia-Hung Lin, et al.
Published: (2015-01-01)

Addressing the Shortage of GLP-1 RA and Dual GIP/GLP-1 RA-Based Therapies—A Systematic Review
by: Velimir Altabas, et al.
Published: (2025-06-01)

Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (α-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells.
by: Salvatore Piro, et al.
Published: (2014-01-01)

Comparative Effects of GLP-1 and GLP-2 on Beta-Cell Function, Glucose Homeostasis and Appetite Regulation
by: Asif Ali, et al.
Published: (2024-11-01)

Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist
by: Gentinetta S, et al.
Published: (2024-12-01)

Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01)

The protective role of GLP-1 in neuro-ophthalmology
by: Sohum Sheth, et al.
Published: (2023-08-01)

Weighing the evidence on GLP1s and venous thromboembolism
by: Damon E. Houghton, et al.
Published: (2025-05-01)

Circulating GLP-1 Levels in Patients with Pheochromocytoma/Paraganglioma
by: Nan Chen, et al.
Published: (2022-01-01)

GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions
by: Michael Bartkoski, et al.
Published: (2025-06-01)

The Impact and Safety of GLP‐1 Agents and Breast Cancer
by: Kayla Parsons, et al.
Published: (2025-06-01)

REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION
by: Zainab M. Al-Shammaa, et al.
Published: (2025-07-01)

Foundational contributions of Svetlana Mojsov to the GLP-1 field
by: George Barany, et al.
Published: (2024-10-01)

Holding GLP-1 Agonists Prior to Elective Procedures
by: Patient Safety Authority
Published: (2023-12-01)

Fasting GLP-1 Levels in Women with PCOS and CAH
by: Robeva R., et al.
Published: (2024-12-01)

Evaluating the Effect on Total Daily Insulin Dose in Adult Patients with Type 1 Diabetes Managed with Metformin and/or GLP-1 or GLP-1/GIP Receptor Agonists
by: Mayeesha Ahmed, et al.
Published: (2025-02-01)

Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system.
by: Jennifer E Richard, et al.
Published: (2015-01-01)

A clinical case of asymptomatic pancreatic hyperenzymemia on the background of taking a Glucagon-like peptide-1 analogue (GLP-1)
by: N.A. Sanina, et al.
Published: (2023-09-01)

Everestmab, a novel long-acting GLP-1/anti GLP-1R nanobody fusion protein, exerts potent anti-diabetic effects
by: Hongchao Pan, et al.
Published: (2020-01-01)

WCN25-3765 Title: Acalculous Cholecystitis, A rare complication of GLP 1 Receptor Agonist (GLP1 RA) after kidney transplant
by: Harshil Fichadiya, et al.
Published: (2025-02-01)

GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway
by: Liufeng Wei, et al.
Published: (2022-01-01)

Indeed, safety comes first for the use of GLP‐1RAs
by: Amruta D. S. Pathare, et al.
Published: (2025-05-01)

Are GLP-1 Analogues a New Solution for the Treatment of NAFLD?
by: Maria Sudoł, et al.
Published: (2024-12-01)

Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
by: Andrew Overholser, et al.
Published: (2025-02-01)

GLP-1 Receptor Agonists’ Impact on Fertility - A Review
by: Joanna Wojda, et al.
Published: (2025-02-01)

Hepatoprotective Benefits of SGLT-2 Inhibitors and GLP-1 Analogs
by: Divya Rajagopal, et al.
Published: (2024-10-01)

Effect and mechanism of GLP-1 on cognitive function in diabetes mellitus
by: Xiaoke Dou, et al.
Published: (2025-03-01)

Patients’ experiences with GLP1-RAs – a systematic review
by: Christoffer Kraul Ibsen, et al.
Published: (2025-04-01)

GLP-1, SGLT-2, new devices for interventional cardiologists
by: Çetin Erol
Published: (2021-02-01)

A Closer Look at the Dermatological Profile of GLP-1 Agonists
by: Calista Persson, et al.
Published: (2025-04-01)

Mechano-regulation of GLP-1 production by Piezo1 in intestinal L cells
by: Yanling Huang, et al.
Published: (2024-11-01)

A Comprehensive Review on the Pharmacokinetics and Drug&minus;Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist
by: Min JS, et al.
Published: (2025-04-01)

Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
by: Rui Salvador, et al.
Published: (2025-03-01)

Ensuring safety first: GLP‐1RAs in reproductive and endometrial research
by: Paola Viganò, et al.
Published: (2025-05-01)